Laboratory Devoted to Improving the Quality of Clinical Testing
MILFORD, Mass.--(BUSINESS WIRE)--Mar. 17, 2016--
At a ceremony at the University of California San Diego School of
Medicine, Waters Corporation (NYSE:WAT) officially welcomed the
for Advanced Laboratory Medicine into the Waters
Centers of Innovation (COI) Program. Under the direction of
Professor Robert Fitzgerald, Director of Toxicology and Associate
Director of Clinical Chemistry, the laboratory develops, validates and
implements liquid chromatography-mass spectrometry (LC-MS) diagnostic
tests, including broad spectrum screens for drugs of abuse, therapeutic
drug monitoring and vitamin D testing.
This Smart News Release features multimedia. View the full release here:
Professor Robert Fitzgerald is Director of Toxicology and Associate Director of Clinical Chemistry at the University of California San Diego School of Medicine. (Photo: Business Wire).
“We are very excited that Waters Corporation has recognized our
department’s work in developing mass spectrometry-based tests for the
clinical laboratory,” said Dr. Steven L. Gonias, Chair of the Department
of Pathology in the UC San Diego School of Medicine and Chief of
Pathology, at UC San Diego Health. “Dr. Fitzgerald and Dr. David Herold
of the UC San Diego School of Medicine have contributed landmark studies
focused on improving the accuracy of diagnostic tests by applying mass
spectrometry in new and innovative ways. The potential to further
improve patient care through the expanded use of mass spectrometry is
Dr. Fitzgerald is one of the world’s foremost experts in the use of mass
spectrometry for the analysis of testosterone and other biologically
important compounds. His laboratory is also a major research center for
studying cardiac biomarkers in diagnosing disease and monitoring
therapeutic interventions. In his role, Dr. Fitzgerald oversees the
activities of three clinical laboratories for UC San Diego Health which
together perform more than 4.5 million assays annually. Dr. Fitzgerald’s
laboratory utilizes several Waters tandem quadrupole and quadrupole time
of flight mass spectrometers, including the Xevo®
G2 QTof™ and ACQUITY® TQD.
“Waters has been an outstanding partner for us and has fully supported
us with robust instrumentation and solid technical support,” Dr.
Fitzgerald said. “I am particularly excited about the aspect of our
collaboration with Waters that allows us to train the next generation of
leaders in clinical chemistry, a field in which mass spectrometry is
becoming increasingly important.”
“It’s a pleasure to welcome the UC San Diego School of Medicine into our
COI Program. Largely due to the efforts of scientists like Dr.
Fitzgerald and his colleagues, the value of LC and MS in the clinical
laboratory has been clearly proven and is having lasting benefits in the
clinic,” said Eric Fotheringham, Director of the Waters Centers of
In 2013, Waters endowed a postdoctoral Clinical Chemistry Fellowship at
UC San Diego. The two-year program trains Fellows in classical clinical
chemistry, laboratory administration and research practices to prepare
them for directorship positions at medical schools or hospital-based
clinical chemistry laboratories.
To salute the work of Prof. Fitzgerald and the Center for Advanced
Laboratory Medicine, Waters Corporation is sponsoring a clinical science
symposium. Titled Mass
Spectrometry in the Modern Clinical Laboratory, the event
features presentations by noted experts in clinical chemistry including Marilyn
Huestis of the University of Maryland Baltimore School of Medicine; Andy
Hoofnagle of the University of Washington; Kara
Lynch of the University of California, San Francisco; Gary
Siuzdak of the Scripps Center for Metabolomics; Frederick
Strathman of the ARUP Institute for Clinical and Experimental
Pathology; Judy Stone of UC San Diego; and Arash Zarrine-Afsar of the
University of Toronto.
About the Center for Advanced Laboratory Medicine at UC San Diego
School of Medicine
The UC San Diego School of Medicine’s Center for Advanced Laboratory
Medicine (CALM) houses the Department of Pathology’s Division of
Laboratory Medicine. The facility features state-of-the-art technologies
used in diagnostic medicine and pathology to support patient care and
inquiry into emerging fields, such as personalized medicine, genomics,
clinical proteomics and cell therapy.
About Waters Centers of Innovation Program
Established in 2010, Waters
Centers of Innovation Program recognizes accomplished scientists and
their institutions for research in the fields of the health sciences,
pharmaceuticals, chemical materials, food and environmental chemistry,
mass spectrometry and separations science. By partnering with leading
scientists and connecting them with experts in mass spectrometry and
separations science, Waters endeavors to bring about inspired thinking
that converts ideas into reality.
The participants in the Waters Centers of Innovation Program include: Professor
Ganesh Anand, National University of Singapore; Professor
Luiz Claudio Cameron, UniRio, Brazil; Professor
David Clemmer, Indiana University; Professor
Daniel Tsun-Yee Chiu, Chang Gung University; Dr.
Joseph Dalluge, University of Minnesota; Dr.
Petur Weihe Dalsgaard, University of Copenhagen; Professor
Marcos Eberlin, University of Campinas, Brazil; Professor
Chris Elliott, Queen’s University Belfast; Professor
John Engen, Northeastern University; Prof.
Rob Fitzgerald, University of California – San Diego; Professor
Albert J. Fornace, Jr., Georgetown Lombardi Comprehensive Cancer
David Goodlett and Dr.
Maureen Kane, University of Maryland; Professor
De-an Guo, Shanghai Institute of Materia Medica; Dr.
Frank Gonzalez, National Cancer Institute; Prof. Ron Heeren, Maastricht
University; Prof. Sunghwan Kim, Kyungpook
National University, Seoul, Korea; Dr.
Carlo R. Largiadèr, Dr. Jean-Francois DuFour and Dr. Martin Fiedler,
Inselspital University Hospital, Bern, Switzerland; Professor
Julie Leary, University of California – Davis; Professor
Amit Kumar Mandal, St. John’s Research Institute, Bangalore, India; Professor
John McLean, Vanderbilt University; Professor
Arthur Moseley, Duke University; Professor
Jeremy Nicholson, Imperial College London; Dr.
Devin Peterson, University of Minnesota; Associate
Professor Jessica Prenni, Colorado State University; Dr.
Serge Rezzi, Nestle Institute of Health Sciences; Dr.
Ryan Rodgers, Future Fuels Institute, Florida State University; Professor
Pauline Rudd, National Institute for Bioprocessing Research and
James Scrivens, University of Warwick; Professor
Vladimir Shulaev, University of North Texas; Dr.
Norman Smith, Kings College London; Professor
Sarah Trimpin, Wayne State University; Professor
Bert van Bavel, NIVA, Oslo, Norway; Caroline
West and Eric Lesselier, University of Orleans, Orleans, France; and Prof.
Vicki Wysocki, The Ohio State University.
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT) develops and manufactures advanced
analytical and material science technologies for laboratory dependent
organizations. For more than 50 years, the company has pioneered a
connected portfolio of separations science, laboratory information
management, mass spectrometry and thermal analysis systems.
Waters, ACQUITY, UltraPerformance LC, QTof and Xevo are trademarks of
View source version on businesswire.com: http://www.businesswire.com/news/home/20160317005073/en/
Source: Waters Corporation
Brian J. Murphy, +1-508-482-2614